A new purified, well-tolerated botulinum neurotoxin, XEOMIN® (pronounced ‘XEE-oh-min’)is now available in Malaysia. Manufactured in Germany and approved by the United States Food and Drug Administration (FDA) since 2011, XEOMIN® is the new botulinum neurotoxin as an aesthetic medicine for the treatment of wrinkles caused by facial expressions. It is injected into the muscles that are involved in wrinkle production and causes a transient relaxation of the muscles. This smoothens out expression-related wrinkles. The face appears younger and fresher, with the natural expression maintained.
XEOMIN® is distinct from other similar products approved for cosmetic use as it has the lowest foreign protein content of the available botulinum neurotoxin preparations. It is the only one free from complexing proteins, leaving only the purified neurotoxin as the active ingredient.
In order to develop XEOMIN® , an innovative manufacturing and purification process was used to separate the complexing proteins from the pure neurotoxin to generate a stable form of the pure neurotoxin.
BOTOX and XEOMIN® have comparable effectiveness. XEOMIN® is a muscle relaxant, it does not block muscles. It can be stored at room temperature for up to 3 years while other botulinum neurotoxins on the market need to be stored in refrigerators in order to maintain their stability/effectiveness.
As XEOMIN® is free of complexing proteins, this results in cleaner molecules and gives consistent and predictable results. Presenting XEOMIN® at the launch was Dr Tatjana Pavicic, an internationally leading expert in aesthetic dermatology with a focus on botulinum toxin, fillers, laser and energy-based devices and cosmeceuticals. Also at the launch was Dr Lim Ting Song, Aesthetic Physician.